SUBSCRIBE
SUBSCRIBE

Dana-Farber Cancer Institute

NEWS
Genetown
Prostate Cancer Hormonal Therapy Cuts Deaths, Dana-Farber Cancer Institute and Brigham and Women’s Hospital Study
December 7, 2011
 · 
1 min read
Genetown
Colon Cancer Prognosis Worse for the Obese, Type 2 Diabetics, Harvard Medical School and Dana-Farber Cancer Institute Study
December 5, 2011
 · 
1 min read
Genetown
Drug May Dampen Dangerous Side Effect of Stem Cell Transplants, Dana-Farber Cancer Institute Study
December 1, 2011
 · 
1 min read
Genetown
Predicting How Cancers Will Respond to Chemo: New Test Determines Whether Tumor Cells Are Already ‘Primed’ for Death, Dana-Farber Cancer Institute Study
October 31, 2011
 · 
1 min read
Genetown
Fetal Hemoglobin Production Reverses Sickle Cell Anemia, Dana-Farber Cancer Institute Study
October 14, 2011
 · 
4 min read
Genetown
Dana-Farber Cancer Institute Slams New Prostate-Cancer Test Guidelines
October 10, 2011
 · 
1 min read
Genetown
Blocking Molecular Target Could Make More Cancers Treatable With PARP Inhibitors, Dana-Farber Cancer Institute Study
June 30, 2011
 · 
1 min read
Drug Development
Promising Target for AIDS Vaccine, Dana-Farber Cancer Institute Study Reveals
April 1, 2011
 · 
1 min read
Genetown
Aspirin May Protect Against Colorectal Cancer -- But Only in Certain People, Massachusetts General Hospital and Dana-Farber Cancer Institute Study
March 14, 2011
 · 
1 min read
Load More
JOBS
IN THE PRESS
Business
Dana-Farber Cancer Institute Appoints Chief Operating Officer, Chief Financial Officer
August 1, 2012
 · 
1 min read
Policy
Cellceutix Novel Anti-Cancer Drug Kevetrin(TM) Receives IRB and SRC Approvals for Clinical Trials at Harvard’s Dana-Farber Cancer Institute
June 26, 2012
 · 
5 min read
Genetown
Publicity Club of New England Presents Dana-Farber Cancer Institute with $2,000 Check
June 8, 2012
 · 
1 min read
Genetown
Dana-Farber Cancer Institute’s Belfer Institute for Applied Cancer Science to Present at American Association for Cancer Research Special Conference Molecular Targeted Therapies: Mechanisms of Resistance
May 3, 2012
 · 
1 min read
Genetown
Dana-Farber Cancer Institute’s Belfer Institute for Applied Cancer Science to Present and Lead Sessions at the American Association for Cancer Research Annual Meeting 2012
March 26, 2012
 · 
1 min read
Business
Koch Institute, Dana-Farber Cancer Institute/ Harvard Cancer Center Announce Launch of “Bridge Project” to Attack Most Lethal Forms of Cancer
March 6, 2012
 · 
1 min read
Business
Dana-Farber Cancer Institute’s Belfer Institute for Applied Cancer Science Appoints New Head of Research
February 14, 2012
 · 
1 min read
Business
OncoPep Enters Exclusive License Agreement with Dana-Farber Cancer Institute for Novel Therapeutic Multi-Peptide Vaccine Technology for Hematologic Cancers
February 13, 2012
 · 
1 min read
Business
Foundation Medicine and Dana-Farber Cancer Institute Identify Novel Genomic Alterations in Lung and Colorectal Cancer
February 13, 2012
 · 
1 min read
Genetown
Massachusetts Life Sciences Center Grant Expands Dana-Farber Cancer Institute Imaging Research Program
January 31, 2012
 · 
5 min read
Load More